z-logo
open-access-imgOpen Access
MYC-Dependent PI3K and MCL-1 Feedbacks Attenuate BET Inhibitors Activity in Diffuse Large B-Cell Lymphoma
Author(s) -
Enrico Derenzini,
Patrizia Mondello,
Yuxuan Liu,
Mary I. Scallion,
Zahra Asgari,
John Philip,
Patrick Hilden,
Hakim Djaballah,
Ouathek Ouerfelli,
Elisa de Stanchina,
Venkatraman Seshan,
Ronald C. Hendrickson,
Andrew D. Zelenetz,
Anas Younes
Publication year - 2016
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.v128.22.294.294
Subject(s) - pi3k/akt/mtor pathway , cancer research , bromodomain , bet inhibitor , venetoclax , downregulation and upregulation , protein kinase b , chemistry , biology , signal transduction , epigenetics , chronic lymphocytic leukemia , microbiology and biotechnology , leukemia , immunology , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom